23 March 2018

2RT to Feature at European Laser Innovation Forum 2018

pdf-icon-small

Adelaide, Australia 23 March 2018 – Ellex Medical Lasers Limited (ASX:ELX), a global leader

in medical devices for the diagnosis and treatment of eye disease, today announced the agenda

for a panel discussion on the Company’s proprietary 2RT® Retinal Rejuvenation Therapy at the

European Laser Innovation Forum to be held in Nice, France on 24 March 2018.

2RT® is Ellex’s breakthrough laser therapy which has the potential to positively influence the

lives of millions of people suffering from age-related macular degeneration (AMD) in its early

stages. An interventional treatment, 2RT® may allow physicians to treat patients at a stage of

the disease for which there is no alternative therapy. It may also defer or eliminate the need for

expensive, invasive pharmaceuticals that are currently used in the late stage of the disease.

Sponsored by Ellex, the forum will enlist a panel of world-renowned faculty, including John

Marshall, PhD, FRCPath, to share their collective experiences and latest updates for 2RT®.Ellex

believes that this is an important initiative given the expected completion of the 2RT® LEAD

clinical trial in mid 2018.

 

Topics to be discussed at the forum include:

“Early to intermediate AMD: Where are we today?”

Moderators: Prof. John Marshall and Dr. Isabelle AKNIN

Speaker: Dr. Isabelle AKNIN

 

“2RT: The Mechanism of Action”

Moderators: Prof. John Marshall and Dr. Isabelle AKNIN

Speaker: Prof. John Marshall

 

“2RT: Publications and Research”

Moderators: Prof. John Marshall and Dr. Isabelle AKNIN

Speaker: Prof. Andrea Cusumano

 

“Clinical Experience and Case Reports with 2RT and AMD and CSME”

Moderators: Prof. John Marshall and Dr. Isabelle AKNIN

Speaker: Dr. Ann Swiech-Zubilewicz

 

“Clinical Experience and Case Reports with 2RT and AMD and CSME”

Moderators: Prof. John Marshall and Dr. Isabelle AKNIN

Speaker: Dr. Alain Mayeras

 

“Clinical Experience and Case Reports with 2RT and AMD and CSME”

Moderators: Prof. John Marshall and Dr. Isabelle AKNIN

Speaker: Dr. Hakan Kaymak

 

The Laser Innovation Forum coincides with the publication of a white paper addressing the

2RT® method of action by Professor Marshal. The paper, entitled “Rejuvenating Bruch’s

Membrane” (attached), describes the scientific and clinical history of 2RT®.

Read the whitepaper

 


 

ABOUT THE SPEAKERS

Prof. John Marshall (United Kingdom)

Professor John Marshall is an internationally recognised expert on laser and light bio-effects in

the field of ophthalmology. He is a Fellow of the Academy of Medical Sciences, Emeritus

Professor of Ophthalmology at King’s College London and an honorary distinguished Professor

in Visual Science at the University of Cardiff. He is also honorary Professor of Ophthalmology

in the Institute of Ophthalmology, University College London. Professor Marshall is the coinventor

of the world’s first diode laser for ophthalmology and the inventor of excimer laser

technology for refractive surgery. During the past 30 years, his research has shed light on the

mechanism underlying age-related, diabetic and inherited retinal disease, and on the

development of lasers for use in ophthalmic diagnosis and surgery. Professor Marshall served

as Chairman of Ellex’s Medical Advisory Board and has over 40 years of ophthalmology

experience.

 

Dr. Isabelle Aknin (France)

Dr. Isabelle Aknin specializes in retinal diseases and ocular aging pathologies. She is currently

appointed at Oxford Private Hospital in Cannes and is also associated with the Hospital of La

Fontonne in Antibes. Dr. Aknin is an angiography Consulting Member of the SFO (Société

Française d’Ophtalmologie), the French Society of Retina, the American Diabetes Association,

the ARVO, the American Academy of Ophthalmology (AAO) and the International Ocular

Inflammation Society. She also co-founded the independent association “ARMD –

Mediterranean Retina Association” in 2008 with Dr. Melki (France). A winner of the 2009 Prize

of the French Society of Retina, she is an expert in retinal disease management and treatment.

 

Prof. Andrea Cusumano – Rome Vision Clinic – Rome (Italy)

Prof. Anna Swiech-Zubilewicz – University Hospital of Lublin – Lublin (Poland)

Dr. Roxana Fulga- Brayer, Kaymak, Klabe Privatpraxis – Düsseldorf (Germany)

Dr. Alain Mayeras – Ophtalliance Centre d’Ophtalmologie – Challans (France)

 


 

ABOUT 2RT

A non-thermal laser therapy, Retinal Rejuvenation Therapy, 2RT®, stimulates a natural,

biological healing response in the eye and in a pilot study on 50 patients has demonstrated

potential as an intervention which may positively influence early Age-Related Macular

Degeneration. 2RT® offers the potential to apply treatment earlier in the disease process with

the aim of slowing retinal degeneration, thereby eliminating or delaying the risk of visionthreatening

complications associated with the late-stage of retinal disease.

 


 

ABOUT ELLEX

Ellex designs, develops, manufactures and sells innovative products that help eye surgeons

around the world to effectively and efficiently treat eye disease. Ellex is a world leader in this

field. Headquartered in Adelaide, Australia, Ellex has ophthalmic lasers and devices that treat

glaucoma, retinal disease primarily caused by diabetes, secondary cataract and vitreous

opacities, as well as age-related macular degeneration. Manufacturing is carried out in

Adelaide, Australia and Fremont, California. Sales and service directly to eye surgeons is

conducted via subsidiary offices in Fremont, Minneapolis, Lyon, Berlin and Tokyo. A network of

more than 50 distribution partners around the world services other markets.

For additional information about Ellex and its products, please visit www.ellex.com

 

For further information on Ellex please contact:

Tom Spurling, CEO

Ellex Medical Lasers Limited

3 Second Avenue, Mawson Lakes, SA, 5095

W +61 8 7074 8200 | M +61 417 818 658

tspurling@ellex.com

Mark Lindh, Investor Relations & Corporate

W +61 8 87074 8200 | M +61 414 551 361

mlindh@ellex.com

Maria Maieli, CFO & Company Secretary

Ellex Medical Lasers Limited

3 Second Avenue, Mawson Lakes, SA, 5095

W +61 8 7074 8200

mmaieli@ellex.com